Dapagliflozin May Be Cost-Effective for Chronic Kidney Disease, Review Finds
A systematic review of 14 economic evaluations across 12 countries finds dapagliflozin plus standard care may be cost-effective or dominant ...
Tag: willingness-to-pay threshold
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development